Kardigan
Last verified 2026-05-14. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $554.0Mattributed |
|---|---|
| Latest round | series-b, $254.0M, 2025-10-14attributed |
| Founded | 2025 |
| Headquarters | South San Francisco, CA |
| Industry | biotech |
| Stage | series-b+ |
| Website | kardigan.bio |
Kardigan develops cardiovascular drugs personalized to individual disease drivers, with a late-stage portfolio for genetic dilated cardiomyopathy, severe hypertension, and calcific aortic valve stenosis. It treats cardiovascular patients underserved by one-size-fits-all therapies. Kardigan stratifies patients by molecular profile.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-10-14 | series-b | $254.0M | undisclosed |
Detected tech stack
Cloudflare, WordPress, Typekit, Adobe Fonts, Yoast SEO 27.4, reCAPTCHA, Google Analytics, Google Tag Manager, FitVids.JS, Font Awesome, jQuery Migrate, Cloudflare Bot Management
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series B, $254.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $554.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | kardigan.bio, read 2026-05-14 |
| Description | self-reported | kardigan.bio, read 2026-05-14 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.